Did Medicare Part D reduce mortality?

Journal of Health Economics

Volumn 53, Issue , 2017, Pages 17-37

  Huh, Jason ^a   Reif, Julian ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DRUG PRESCRIBING; ELDERLY CARE; HEALTH SERVICES; MORTALITY;

ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; DRUG COST; EMPLOYMENT STATUS; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; INCOME; LOWEST INCOME GROUP; MEDICAID; MEDICARE; MORTALITY RATE; PRESCRIPTION; SURVIVAL RATE; VALIDATION PROCESS; AGED; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; ECONOMICS; EPIDEMIOLOGY; MORTALITY; TRENDS; UNITED STATES;

PRESCRIPTION DRUG;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HUMANS; MEDICARE PART D; PRESCRIPTION DRUGS; UNITED STATES;

EID: 85014332997     PISSN: 01676296     EISSN: 18791646     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2017.01.005     Document Type: Article

References (43)

1. Aronow, H.D., Topol, E.J., Roe, M.T., Houghtaling, P.L., Wolski, K.E., Lincoff, A.M., Harrington, R.A., Califf, R.M., Ohman, E.M., Kleiman, N.S., et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet 357:9262 (2001), 1063–1068.
2. Baicker, K., Taubman, S.L., Allen, H.L., Bernstein, M., Gruber, J.H., Newhouse, J.P., Schneider, E.C., Wright, B.J., Zaslavsky, A.M., Finkelstein, A.N., The Oregon experiment – effects of medicaid on clinical outcomes. N. Engl. J. Med. 368:18 (2013), 1713–1722.
3. Basu, A., Yin, W., Alexander, G.C., Impact of Medicare Part D on Medicare–Medicaid dual-eligible beneficiaries’ prescription utilization and expenditures. Health Serv. Res. 45:1 (2010), 133–151.
4. Bernard, D., Cowan, C., Selden, T., Cai, L., Catlin, A., Heffler, S., Reconciling medical expenditure estimates from the MEPS and NHEA 2007. Medicare Medicaid Res. Rev., 2(4), 2012.
5. Bhattacharya, J., Goldman, D., Sood, N., The link between public and private insurance and HIV-related mortality. J. Health Econ. 22:6 (2003), 1105–1122.
6. Brook, R.H., Ware, J.E. Jr., Rogers, W.H., Keeler, E.B., Davies, A.R., Donald, C.A., Goldberg, G.A., Lohr, K.N., Masthay, P.C., Newhouse, J.P., Does free care improve adults’ health? Results from a randomized controlled trial. N. Engl. J. Med. 309:23 (1983), 1426–1434.
7. Cannon, C.P., Braunwald, E., McCabe, C.H., Rader, D.J., Rouleau, J.L., Belder, R., Joyal, S.V., Hill, K.A., Pfeffer, M.A., Skene, A.M., Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med. 350:15 (2004), 1495–1504.
8. Card, D., Dobkin, C., Maestas, N., Does medicare save lives?. Q. J. Econ. 124:2 (2009), 597–636.
9. Clayton, D., The Effect of Prescription Drug Coverage on Mortality: Evidence From Medicaid Implementation. Working Paper. 2014.
10. Congressional Budget Office, Updated Estimates of the Effects of the Insurance Coverage Provisions of the Affordable Care Act. 2014.
11. Cutler, D., McClellan, M., Newhouse, J., The costs and benefits of intensive treatment for cardiovascular disease. Meas. Prices Med. Treat., 34, 1999.
12. Cutler, D.M., Your Money or Your Life: Strong Medicine for America's Health Care System. 2004, Oxford University Press.
13. Davidoff, A.J., Shaffer, T., Erten, M.Z., Shoemaker, J.S., Zuckerman, I.H., Pandya, N., Stuart, B.C., Bryant-Comstock, L.G., Shenolikar, R., Use and spending on antineoplastic therapy for medicare beneficiaries with cancer. Med. Care 51:4 (2013), 351–360.
14. Deryugina, T., Heutel, G., Miller, N.H., Molitor, D., Reif, J., The Mortality and Medical Costs of Air Pollution: Evidence From Changes in Wind Direction. Working Paper. 2016.
15. Domino, M., Farley, J., Did Medicare Part D improve access to medications?. Psychiat. Serv. 61 (2010), 118–120.
16. Engelhardt, G.V., Gruber, J., Medicare Part D and the financial protection of the elderly. Am. Econ. J. Econ. Policy 3:4 (2011), 77–102.
17. Finkelstein, A., McKnight, R., What did medicare do? The initial impact of medicare on mortality and out of pocket medical spending. J. Public Econ. 92:7 (2008), 1644–1668.
18. Gowrisankaran, G., Town, R., Barrette, E., Managed care, drug benefits and mortality: an analysis of the elderly. BE J. Econ. Anal. Policy, 11(2), 2011.
19. Grossman, M., On the concept of health capital and the demand for health. J. Polit. Econ., 80(2), 1972, 223.
20. Haffner, S.M., Lehto, S., Rönnemaa, T., Pyörälä, K., Laakso, M., Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339:4 (1998), 229–234.
21. Hassol, A., Jureidini, S., Doksum, T., Hadden, L., Evaluation of the Medicare-Approved Prescription Drug Discount Card and Transitional Assistance Program. Final Report to the Centers for Medicare & Medicaid Services. 2006.
22. Jorgenson, D.W., Yun, K.-Y., Investment, Vol. 3: Lifting the Burden: Tax Reform, the Cost of Capital, and US Economic Growth. 2002, MIT Press Books.
23. Kaestner, R., Khan, N., Medicare Part D and its effect on the use of prescription drugs and use of other health care services of the elderly. J. Policy Anal. Manag. 31:2 (2012), 253–279.
24. Kaestner, R., Long, C., Alexander, G.C., Effects of Prescription Drug Insurance on Hospitalization and Mortality: Evidence From Medicare Part D. Working Paper. 2014.
25. Lakdawalla, D., Philipson, T., Does intellectual property restrict output? An analysis of pharmaceutical markets. J. Law Econ. 55:1 (2012), 151–187.
26. Levy, H., Meltzer, D., What do we really know about whether health insurance affects health. Health Policy Uninsured, 2004, 179–204.
27. Lewington, S., Whitlock, G., Clarke, R., Sherliker, P., Emberson, J., Halsey, J., Qizilbash, N., Peto, R., Collins, R., Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet, 370(1829), 2007, 1839.
28. Lichtenberg, F.R., The effects of medicare on health care utilization and outcomes. Front. Health Policy Res., 5(3), 2002.
29. Lichtenberg, F.R., Sun, S.X., The impact of Medicare Part D on prescription drug use by the elderly. Health Aff. 26:6 (2007), 1735–1744.
30. Lurie, N., Ward, N.B., Shapiro, M.F., Brook, R.H., Termination from Medi-Cal–does it affect health?. N. Engl. J. Med. 311:7 (1984), 480–484.
31. McInerney, M., Mellor, J.M., Recessions and seniors’ health, health behaviors, and healthcare use: analysis of the medicare current beneficiary survey. J. Health Econ. 31:5 (2012), 744–751.
32. Medicare Board of Trustees, 2004 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. 2004.
33. Medicare Board of Trustees, 2014 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. 2014.
34. Mosca, L., Barrett-Connor, E., Wenger, N.K., Sex/gender differences in cardiovascular disease prevention what a difference a decade makes. Circulation 124:19 (2011), 2145–2154.
35. National Center for Health Statistics, Health, United States, 2013: With Special Feature on Prescription Drugs. 2014.
36. Nelson, L., How Many People Lack Health Insurance and For How Long? Congress of the US, Congressional Budget Office. 2003.
37. Rathore, S.S., Wang, Y., Krumholz, H.M., Sex-based differences in the effect of digoxin for the treatment of heart failure. N. Engl. J. Med. 347:18 (2002), 1403–1411.
38. Ruhm, C.J., Recessions, Healthy No More? NBER Working Paper. 2013.
39. Schneeweiss, S., Patrick, A.R., Pedan, A., Varasteh, L., Levin, R., Liu, N., Shrank, W.H., The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff. 28:2 (2009), w305–w316.
40. Sommers, B.D., Baicker, K., Epstein, A.M., Mortality and access to care among adults after state medicaid expansions. N. Engl. J. Med. 367:11 (2012), 1025–1034.
41. Sommers, B.D., Long, S.K., Baicker, K., Changes in mortality after Massachusetts health care reform: a quasi-experimental study. Ann. Intern. Med. 160:9 (2014), 585–593.
42. Weingart, S., Brown, E., Bach, P., Eng, K., Johnson, S., Kuzel, T., Langbaum, T., Leedy, R., Muller, R., Newcomer, L., et al. NCCN task force report: oral chemotherapy. J. Natl. Compr. Cancer Netw. 6 (2008), S1–14.
43. Zimmer, D.M., The Effect of Medicare Part D on Prescription Drug Composition and Demand. Working Paper. 2014.